Tim F. Greten, Donna Mabry Hrones, Cecilia Monge, Nebojsa Skorupan, David E. Kleiner, Bradford Wood, Bernadette Redd. "A phase I/II study of CDX-1140, a CD40 agonist, in combination with capecitabine and oxaliplatin (CAPOX) and pembrolizumab in subjects with biliary tract carcinoma: Phase 1 results.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4129